ImaginAb, GSK CIC conclude two research collaboration agreements
ImaginAb, Inc. and the GSK Clinical Imaging Centre (part of the GlaxoSmithKline Group of Companies) have concluded two research collaboration agreements around a clinical therapeutic antibody asset currently under development by GSK in the field of oncology.
Leave a Response
You must be logged in to post a comment.
